Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Harefuah|April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.
Hematological Oncology|July 8, 2020
Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survivalErel Joffe, Uri Greenbaum, Gili Man-El, et al.
European Journal of Gastroenterology & Hepatology|January 3, 2020
Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population studyVitaly Dizengof, Itai Levi, Ohad Etzion, et al.
Acta Haematologica|December 17, 2023
The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working GroupDrorit Merkel, Shelly Soffer, Kalman Filanovsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2020
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?Uri Greenbaum, Fevzi F Yalniz, Samer A Srour, et al.
European Journal of Haematology|June 30, 2018
Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?Uri Greenbaum, Erel Joffe, Kalman Filanovsky, et al.
Haematologica|April 23, 2026
Local cytokine release syndrome with cervical angioedema following CAR-T cell therapyKarney Lahad, Ofrat Beyar-Katz, Mohamad Dallasheh, et al.
Cancer|February 4, 2023
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantationJun Zou, Piyanuch Kongtim, Betül Oran, et al.
European Journal of Haematology|June 28, 2018
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trialsErel Joffe, Neta Goldschmidt, Osnat Bairey, et al.
Hematological Oncology|June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survivalErel Joffe, N Ariela Arad, Osnat Bairey, et al.
Pageof 5